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The cutaneous localization of intravenously injected 
preformed immune complexes was examined in C57Bl/ 
6J mice and the importance of complex size and antibody 
charge was assessed for deposit ion and persistence in 
cutaneous structures. 
After a s ingle intravenous bolus, large-latticed com-
plexes deposited transiently in an interstitial extrava-
sated pattern, and persisted longer in a vascular pattern. 
S mall-latticed complexes, prepared a t 50 times antigen 
excess, did not deposit. When large-latticed complexes 
w ere prepared with reduced a nd alkylated antibodies, 
t heir vascular deposition was similar, but they did not 
localize in the interstitium due to decreased extravasa-
t ion. Large-latticed complexes prepared with cationized 
antibodies deposited in a vascula r and interstitial pat-
tern as well as at the dermal-epidermal junction. Com-
plexes prepared with anionized antibodies deposited 
comparable to unaltered complexes. 
Cutaneous deposition of circulating immune com-
plexes in mice r equires a large lattice. Circulating im-
mune complexes formed with cationic a ntibodies deposit 
a t the dermal-epidermal junction. 
Circulating immune complexes have been found and impli-
cated in t he pathogenesis of many diseases with primary skin 
manifestat ions [1] including erythema mult iforme [2], derma-
titis herpetiformis (3], pityriasis lichenoides et varioliformis 
acuta (4], systemic lupus erythematosus [5], polyarterit is no-
dosa [6), scleroderma [7], cryoglobulinemia [8], and ot her vas-
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Abbreviations: 
Ab: a nt ibody 
AbAc: a nioni zed a nt i-HSA (anti- HSAAc) 
AbEo: cationized ant i-HSA (ant i-HSAm) 
Ag: a nt igen 
5X AgAb: immune complexes prepa red wit h unaltered rabbi t a nt i-
H SA and HSA at 5 t imes ant igen excess 
50xAgAb: immune complexes at 50 t imes ant igen excess 
5XAgAbAc: immune complexes at 5 times a nt igen excess prepared 
wit h anionized a nt ibodies 
5XAgAbEo: im mune complexes at 5 t imes a nt ige n excess prepared 
wit h cationized ant ibodies 
5X AgAbn,, : immune complexes at 5 t imes an t igen excess prepa red 
with reduced a nd alkylated antibodies 
BBS: borate-bu ffe red saline, 0.2 M borate, 0.15 M NaCI, pH 8.0 
DEJ : derma l-epidermal junction 
HSA: huma n seru m a lbumin 
IEF: isoe lectric foc using 
PBS: phosphate-buffered sal ine, 0. 1 M phosphate, 0.15 M NaCl, 
pH 7.2 
SDG: sucrose density gradient 
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culitides [9]. The locations of immune deposits in t hese diverse 
disorders range from vessels to t he dermal-epidermal junction 
(DEJ). Little is known, however, about t he requirements of 
circulating immune complexes for deposit ion and persistence 
in cutaneous structures. 
Various animal models have been examined to understand 
the mechanisms t hat lead to t he different immune deposits 
encountered in human diseases. Cochrane and Weigle [10] 
compared t he vascular lesions seen in the Arthus reaction with 
those found in other organs (heart, aorta, kidney, lung) in 
experimental serum sickness models when both ant igen and 
ant ibody were present in circulation [11) as well as those seen 
with t he passive administration of preformed soluble immune 
complexes [12]. Cochrane and Hawkins [13] fu rther examined 
t he requirements for deposit ion of preformed, injected immune 
complexes in vascular structures (heart and kidney of guinea 
pigs and rabbits) and concluded t hat: (1) only complexes greater 
than 19 Svedberg units would deposit; (2 ) no relationship 
existed between net-charge and deposit ion; and (3) vasoactive 
amines and permeability changes we re required. Recent work 
has defined the importance of t he lattice of immune complexes, 
t he requiremen ts of precipitating ant igen-antibody systems, 
and the cont ribution of charge of ant ibodies and ant igens in 
immune complexes on their localization in renal glomeruli [14-
17]. 
T his work examined t he effect of several variables in pre-
fo rmed immune complexes on their localization in cutaneous 
structures of mice after int ravenous injection. The injected 
complexes were prepared at various degrees of an tigen excess 
to examine the influence of lattice of immune complexes on 
localization in skin . The persistence of immune complexes in 
circulation was prolonged by using ant ibodies with cleaved 
interchain disulfide bonds. The role of ant ibody charge in 
immune complexes on localization in skin was examined by 
chemically cationizing or anionizing the ant ibody molecules 
used for preparation of immune complexes. Deposition in var-
ious regions of skin was compared to deposition in t he kidney, 
hear t, and liver. 
MATERIALS AND METHODS 
Preparation. and Characterization. of Antibodies, Antigen., and Immune 
Complexes 
Pu ri fied, '151-labeled a nt ibodies to human serum albumin (ant i-HSA) 
were prepared according to prev iously desc ribed methods [15]. HSA 
(E. R. Squibb, New Brunswick, New J ersey) was purified by DEAE ion 
excha nge chromatography as well as gel fil t ration. An tibodies were 
cationized by ethylene dia mine linkage to reactive carboxyl groups on 
t he a nt i-HSA by a water-soluble carbodiimide reaction according to a 
p rev iously described method [15]. T he cationic nature of the protein 
was confi rmed by isoelectr ic foc using (IEF), t he monomeric nature 
confi rmed on sucrose density gradient (SDG) analysis, a nd a trin itro-
benzene sul fo nic acid assay was used to quant ify t he number of amino 
groups; all were done by previously described methods [15]. Antibodies 
_;,.e re anionized by acetylation in the cold accordi ng to a previously 
desc ribed method [18]. Reduction and alky lation of ant ibodies was 
pe rfo rmed wit h 0.1 M 2-mercaptoethanol a nd 0.11 M iodacetamide as 
previously described [14 ]. 
Soluble complexes (5xAgAb) were prepared at 5 t imes a nt igen excess 
at room temperature wit h una lte red ant i-HSA determined from the 
poi nt of equivalence by qua nt itative precipitin analysis to be 153 !lg 
HSA/1000 /J. g a nt i-HSA. Soluble, sma ll -latticed complexes (50xAgAb) 
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were prepared as above at 50 times HSA excess. Quantitative precipitin 
analysis was performed with reduced and alkylated anti-HSA, with 
equivalence at 117 J.Lg HSA/1000 11-g anti-H SA and the complexes were 
prepared as above. The immune complexes at 5 times a ntigen excess 
with cation ized anti-HSA (5XAgAbw) and with anionized anti-HSA 
{5XAgAbAc) were prepared as above after quantitative precipitin analy-
sis revea led equivalence points of 117 J.Lg HSA/1000 11-g cationized anti-
HSA and 67 J.Lg HSA/ 1000 11-g anionized anti -HSA. Complexes were 
allowed to equilibrate 3- 4 days at 4•c prior to use and SDG analysis. 
Complexes and antibodies were also equilibrated with mouse serum to 
reproduce initia l and 48-h concentrations as determined by previous 
kinetic data [15] and run on SDG. 
J mmu.nofluorescence Microscopy 
Tissues were obtained immediately after sacrifice of mice, embedded, 
frozen in Tissue Tek II OCT compound (Ames Company, Elkhart, 
india na) and cut for stai ning in 4-J.Lm sections at -2o· c as previously 
described [16]. The following !1uoresceinated antisera were used: goat 
antirabbi t lgG (Kallestad Laboratories, Austin, Texas) diluted 1:40 
with 0.1 M phosphate, 0.15 M NaCl , pH 7.2 buffer (PBS); goat anti-
HSA (N. L. Cappel Laboratories, Cochranville, Pennsylvania) diluted 
1:20 in PBS; goat anti mouse C3 and goat antimouse lgG (N. L. Cappel 
Laboratories) diluted 1:20 in PBS. A grading scale (0- 4+) of intensity 
of immuno!1uorescence was used as previously described for glomeruli 
[15]. For skin and other organs: 4+, dense deposits were visible at 
lOOX; 3+, dense deposits clearly visible in most fie lds at 400X; 2+, 
dense deposits visible in some fields of 400x {10- 50%); 1 +, deposits 
visible in less than 10% fields at 400x; trace, faint deposits vis ible in 
some fields at 400x; ±, rare, faint deposits visible at 400x. A Zeiss 
epit1uoresce nce microscope (Zeiss, Oberkochen, F.R.G.) was used and 
photographs were taken on Tri-X Pan ASA 400 fi lm (Eastman Kodak, 
Rochester, New York) with a 20-s to 40-s exposure time. 
Experimental Design 
Female C57B l/6J mice (18- 24 g) received Kl in their drinking water 
prior to injection and throughout. the experiment. The test protein was 
injected in to the ta il vein in a 0.5 ml volume of borate-buffered saline 
(0.2 M borate, 0.15 M NaCl, pH 8.0, BBS) . For tissue localization 
studies the following materials were injected as 5 mg antibody protein 
or 5 mg antibody protei n in the immune complexes: anti-HSA, HSA (5 
mg) , 5xAgAb, 50XAgAb, 5XAgAbnA, anti-HSAEo. 5XAgAb~m, anti-
HSAAc, 5xAgAbAc· One to t hree mice were sacrificed for each prepa-
ration at varying intervals after injection, inc luding 1 h, 4 h, 8 h, 12 h, 
24 h, 48 h, and specimens of heart, liver, kidney, and skin from the 
posterior !1ank , tail, lip, and ear were frozen immediately and stored at 
-2o· c prior to sectioning. 
RESULTS 
Characterization of Altered Antibodies 
The cationized antibody by the trin itrobenzene sulfonic acid 
assay showed the average number of added amino groups to 
range from 20- 30. On IEF the major proportion of protein had 
a pl > 9.3 with small amounts of less altered lgG present (Fig 
1). A precipitin curve showed that the anti-HSArm was slightly 
less reactive (75% anti-HSAw vs 84% anti-HSA precipitable) 
and possessed an earlier point of maximum precipitation (117 
J.Lg HSA/1000 J.Lg anti-HSAr,;o vs 153 J.Lg HSA/1000 J.Lg anti-
HSA), consistent with some inactivation of antibody by cation-
ization. By SDG analysis anti-HSAw was monomeric. The 
addition of small amounts of radiolabeled anti-HSA or anti-
HSArm to mouse serum showed no reaction with mouse serum 
proteins as determined by SDG. 
The an ionized antibodies by the trinitrobenzene sulfon ic acid 
assay showed an average reduction of 55 amino groups with 
most of the anti-HSA having a pi < 5.2. A precipitin curve 
showed a less reactive antibody (52% precipitable) with an 
earlier point of maximum precipitation (67 J.Lg HSA/1000 J.Lg 
anti-HSAAc), consistent with some inactivation. SDG analysis 
confirmed that anionization did not cause aggregation of the 
antibodies. 
Characterization of Immune Complexes 
Since the lattice of immune complexes influences their lo-
calization in glomeru li, as reviewed in the introduction, all 
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prepared immune complexes were characterized by SDG analy-
sis (Table I) . Five times AgAb and 5xAgAbnA had comparable 
lattices with 44-49% of antibodies in the greater than Ag2Ab2 (> llS) complexes. The amount of unreactive lgG was less than 
10% in these preparations. Fifty times AgAb had only a small 
shoulder of heavier than llS material, as previously described 
[14). When cationized or anion ized anti-HSA were used to 
prepare the complexes, the proportion of greater than 11S 
material was relatively the same, about 40% of the total anti-
bodies in immune complexes, but the monomeric lgG peak now 
comprised 23-27% of the total, indicating inactivation of 16-
20% of the antibody through chemical modification of the 
protein, as compared to the unaltered antibody. When the 
immune complexes were incubated with mouse sera to simulate 
a b c d 
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-
8.45 
-8.15 
-
7.35 
- -
6.55 
• 
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-5.2 
F IG 1. lsoelectric focusing pattern of cationized, anionized, and 
unaltered antibodies. In la.ne a, t he majority of Ab,m has a pi> 9.3 with 
smaller amounts of less cationized materia l. In lane b, the majority of 
AbAc has a pl < 5.2 with smaller amounts of less an ionized materia l. 
Lane c shows unaltered anti-HSA with variable pis. Standards a re in 
lane d. 
TABLE I. S ucrose density gradient a.nalysis of immu.ne complex 
preparations 
Preparation Percent> 11 5" Percent free Ab 
5xAgAb 44.0 6.5 
50xAgAb 9.0 
5XAgAbnA 49.0 3.8 
5XAgAbED 37.4 27.0 
5XAgAb"c 42.0 23.0 
"The percent of antibodies in the > l lS fraction (greater than 
Ag1Ab1 ) of immune complexes or in free antibodies (A b) was calculated 
from the '1"1 activity in each peak and the total radioactivity in the 
gradient. 
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concentrations in mouse circulation immediately and at 48 h 
after injection (90% complexes removed), the lattices were 
comparable, indicat ing that the mouse serum proteins did not 
alter. the lattice of injected complexes. 
Localization of Preformed Immune Complexes in Skin and 
Other Organs 
The inf1uence of the lattice of immune complexes and the 
ro le of antibody charge in localization of circulating immune 
complexes were examined in several regions of the skin, includ-
ing the ear, lip, f1ank, and tail of mice. In addition, deposition 
of immune complexes in blood vessels of the dermis and sub-
cutaneous area, in the loose connective tissue (interstitium), 
and at the DEJ were determined. Since in the studies to be 
presented no predilection for deposit ion of immune complexes 
t o dermal structures of various regions of skin were found, with 
t he exception of the lip, the data will be presented for skin in 
general. The observations on lip will be pointed out and illus-
t rated where differences were identified. The data for skin and 
other organs are listed in Tables II and III , respectively. 
All sections were stained with f1uoresceinated anti -HSA and 
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f1uoresceinated anti rabbit IgG. The data will be presented with 
staining for rabbit lgG though immunof1uorescence patterns 
were comparable in intensity and location with stains for HSA 
when immune complexes were injected. When antibody prep-
arations (Ab, AbAc, Ab1ml were injected alone, t issues did not 
stain for HSA. 
The intravenous inject ion of 5xAgAb resulted in deposition 
of immune complexes in the dermal and subcutaneous vessels 
as detected by immunofluorescence microscopy by staining for 
t he antibodies (rabbit lgG) and the antigen (HSA). By the same 
criteria, immune complexes were also found in the interstit ial 
area but only rarely were immune complexes found at the DEJ. 
Immune complexes in the blood vessel walls were present at 1 
h (2- 3+) and increased by 4 h (3-4+) (Fig 2), markedly declined 
by 8 h (1 + ), and were absent at 48 h. The interstitial deposits 
of immune complexes were most intense at 1 h (2.5- 3+) and 
declined thereafte r, suggesting that extravasation of t hese ma-
terials contributed to their presence in the interstit ium. The 
lip had more intense vascular and interstitial staining than 
other areas of skin. The dermal vascular deposit ion of 5xAgAb 
complexes paralleled the deposition in myocardia l small vessels 
TABLE II. immunofluorescence intensity for rabbit IgG in dermal structures after intravenous injection of various preparations of imm.ttne 
complexes or altered antibodies alone 
l h 4 h B h l 2 h 48 h 
Preparation 
A B c A B c A B c A B c A B c 
5xAgAb: 
Lip 3+ 3+ ± 4+ 2+ ± 1+ t r 0 
Ear, tail , flank 2+ 2.5+ 0 3+ 1.5+ 0 l+ 1+ 0 l+ ± tr 0 0 0 
50xAgAb: 
Lip , ear, ta il, flank 1+ t r ± ± 0 0 ± 0 0 ± 0 0 0 0 0 
5XAgAbnA: 
Lip, ear, tail, flank 3+ tr- 1+ 0 3+ 1+ 0 1.5+ tr 0 1+ tr 0 0 0 0 
AbEo: 
Lip 3+ 3+ ± 3+ 2+ 2+ 2+ 2+ 3+ 1.5+ 1+ 3+ 1+ 1+ 1.5+ 
Ear , tail, f1 ank 2.5+ 2+ ± 2.5+ 2+ 1+ 2+ 1.5+ 1.5+ 1+ 1+ 3+ 0.5+ 1+ 1.5+ 
5xAgAbED: 
L ip 4+ 4+ tr 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 3+ 
Ear, tai l, fl ank 4+ 4+ tr 4+ 4+ 1.5+ 4+ 4+ 2+ 4+ 4+ 2.5+ 3.5+ 3+ 1.5+ 
5XAgAbAc: 
Lip, ear, tail, fl ank 2+ 3+ 0 3+ 2+ 0 1.5+ 1+ 0 1+ l+ 0 0 0 0 
A = vascu la r staining; 8 = interstit ia l staining; C = DEJ staining; t r =trace. 
TABLE Ill. Immunofluorescence intensity for rabbit IgG in other organs after intravenous injection of various preparations of immune complexes 
or altered antibodies alone 
l h 4 h S h 12 h 48 h 
H eart 
5XAgAb 2+ 1+ ± ± 0 
50xAgAb ± ± 0 0 0 
5XAgAbnA 3+ 2.5+ 2+ 1+ 0 
AbEo 3+ 2+ 1.5+ l+ 0 
5XAgAbEu 3+ 4+ 4+ 4+ 2.5+ 
5xAgAbAc 2+ 2+ 1.5+ 1.5+ 0 
Live r 
5XAgAb 3+ 4+ 2+ l+ 0 
50xAgAb 3+ 1.5+ tr 0 0 
5xAgAbnA 1+ 1+ 0.5+ 0 0 
AbED 3+ 2+ l+ 0.5+ 0 
5xAgAbEo 4+ 3+ 3+ 3+ 1.5+ 
5XAgAbAc 3+ 3+ 2+ 1.5+ 0 
1 h 4 h S h 12 h 48 h 
A B A B A B A B A B 
K idney 
5xAgAb 2+ 3+ 2.5+ l+ 3+ t r 3+ tr 0.5+ 0 
50xAgAb tr t r t r tr t r 0 0 0 0 0 
5XAgAbnA 2+ 4+ 3+ 3+ 3+ 2.5+ 4+ 2+ 4+ tr 
AbED 4+ 4+ 4+ 4+ 2+ 2+ 2+ 2+ t r t r 
5XAgAbED 4+ 4+ 4+ 3+ 4+ 2+ 4+ 2+ 4+ 1+ 
5xAgAbAc 2+ 3+ 2.5+ 2+ 3+ 2+ 3+ l+ 3+ 0 
A = Glomerular staining; 8 = extraglomerula r stai ning. 
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FI G 2. Skin immunofluorescence patterns after staining with flu-
oresce inated antibody to rabbit lgG. Four hours after injection of 
5xAgAb the ea r (A), flank (C), and tai l {1)) stained similarly. More 
frequent vascular and interst itial staining was observed in the lip (B). 
T here is no staining at the DEJ (arrowheads ). X 500. 
and in renal peritubular capillaries . Only glomerular deposits 
persisted longer than the deposits in skin, 0.5+ at 48 h. Neither 
antigen (HSA) nor antibody (anti-HSA) alone deposited in 
skin or in other organs by immunofluorescence microscopy. 
The skin and other organs of mice given on ly saline were also 
negative with the same Ouoresceinated antisera. 
Complexes prepared at 50XAgAb did not deposit significantly 
in tissues. Some trace deposits were seen at early time points, 
which may reflect small amounts of >llS material present in 
these preparations (Table I). 
Complexes were prepared with reduced and alkylated anti-
bodies (5XAgAbRA) since these complexes were previously 
shown to have a prolonged persistence in circulation due to 
decreased interaction with Kupffer cell Fe receptors and en-
hanced glomerular and extraglomerular deposition [16]. In this 
study, 5xAgAbHA showed strikingly similar cutaneous vascular 
deposition to unaltered complexes, but exhibited a marked 
decrease in interstitial staining, trace to 1 + at 1 h compared to 
2.5-3+ with unaltered complexes. The latter finding is consist-
ent with previously demonstrated decreased extravasation of 
these complexes [19] . 
The cationized antibodies (anti-HSAED) alone deposited in 
derma l structures. Extensive and prolonged staining for rabbit 
lgG was found at the DEJ t hat increased during the first 12 h 
after injection and persisted at 48 h (Fig 3) . The vascular and 
interstitial dermal t issues initially showed up to 3+ staining 
and stained only 1 + by 12 h. Various skin sites showed a 
characteristic variation in intensity and frequency of DEJ 
deposition: lip > ear, tail> flank. Five times AgAbm deposited 
with a prominent perivascular clustering of both HSA and 
rabbit IgG, and adjacent DEJ deposition that increased between 
the 1- and 4-h time points from trace to 4+ in the lip and 1.5+ 
in other areas of skin. The junctional staining persisted longer 
than 48 h with some clearing of the vascular and interstitial 
space (Fig 4) . Deposition at the DEJ was more persistent and 
intense in the lip with 5xAgAb1m compared to anti-HSArm 
alone (3+ vs 1.5+ at 48 h). 
Anionized antibody (anti-HSAAd alone did not deposit in 
any t issue. Five times AgAbAr deposited in all structures com-
parable to 5xAgAb. 
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The heart, when positive, stained in a perimuscular capillary 
pattern. In addition, with the cationized preparations (anti-
HSAw, 5xAgAbr-:D) intense staining for rabbit IgG was found 
at valve bases. Five times AgAb and 5XAgAbAc deposited only 
transiently, 2+ at 1 h, and declined t hereafter. Five times 
AgAbnA had increased deposition and persistence, 3+ at 1 h 
and 1 + at 12 h. Fifty times A gAb did not deposit in the small 
vessels of the heart. Five times AgAbrm had the most intense 
deposition (4+ at 4, 8, and 12 h) and the longest persistence in 
the heart (2 .5+ at 48 h). 
The liver stained avidly in a Kupffer cell pattern early after 
injection of large- latticed complexes prepared with either un-
altered or anionized anti-HSA (5XAgAb, 5XAgAbAc): 3+ at 1 
h declining to 1-1.5+ at 12 h. Reduction and alkylation of anti-
HSA decreased hepatic uptake of 5xAgAbnA, showing only 1 + 
at 1- 4 h. Both anti-HSAEu and 5XAgAbw were present in a 
perisinusoidal pattern. 
The kidneys had deposits in both a glomerular and extra-
glomerular peritubular capillary pattern. The extraglomerular 
deposition decreased over time with 5xAgAb, 5xAgAbAc, and 
5xAgAbHAsimilar to t he heart capillary and cutaneous vascular 
stain ing. The glomerular deposits increased over time with 
these preparations (2+ at 1 h, 3- 4+ at 12 h) . Anti-HSAED 
deposited intensely at early time points, 4+ glomerular and 
extraglomerular deposits at 1 h, but was only trace at 48 h, a 
time at which the skin still had 1.5+ deposits at the DEJ. Five 
times AgAbrm had prolonged glomerular (4+ at 48 h) and 
extraglomerular deposition (1+ at 48 h). Small-latticed 
50xAgAb did not significantly deposit in glomerular or extra-
glomerular sites. 
DISCUSSION 
The presented data indicate that physicochemical character-
istics of immune complexes have important effects on their 
deposition in cutaneous structures. The unique morphology of 
the skin offers multiple potential and real sites for localization 
of immune complexes. Intravascular complexes may traverse 
or be trapped by the endothelium with its basement membrane 
the interstitial space with collagen, elastin, and anionic glyco: 
proteins [20] or reach the DEJ with its own molecular constit-
uents and fixed anion ic charges [21] . The anionic connective 
tissue glycoproteins and the anionic DEJ have the potential for 
electrostatic interactions with fluid phase polycationic immune 
complexes. 
Only large-latticed immune complexes deposit in t he skin or 
other tissues. Complexes made at 5 times antigen excess 
(5xAgAb, 5XAgAb11A, 5XAgAb"c) contained large amounts of 
immune complexes with more than 2 antibody molecules. These 
complexes formed cutaneous deposits, while complexes made 
at 50 times antigen excess, consisting of small-latticed immune 
complexes (Ag"Ab", Ag,Ab,) did not localize in the skin or other 
tissues. 
Large-latticed complexes (5xAgAb) made with unaltered an-
tibody deposit extensively, yet transiently , in both an interst i-
tial and dermal vascular pattern. The early interstitial pattern 
likely represented extravasation. In a previous kinetic study 
extravasation after injection of 5XAgAb complexes was docu-
mented with a marker protein and hemoconcentration [19]. 
Not all vessels had deposits. This patchy distribution of im-
mune complexes may represent areas of increased permeability 
caused by vasoactive amines or local accumulation of complexes 
[22,23]. Most regions of skin showed comparable degrees and 
patterns of immune complex deposition, with the exception of 
the lip which had an increased frequency and intensity of 
deposition, perhaps secondary to increased vascularity. The 
time course of deposits in renal peritubular capillaries and 
small vessels of the myocardium was comparable to small vessel 
deposits in skin, while glomerular deposits increased during the 
initial hours after injection and persisted the longest of all 
organs examined. 
The mechanisms for removal of immune deposits from the 
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cutaneous interst itial and vascular a reas are not known. The 
possible mechanisms include the solubilization of the large-
latticed complexes by the excess antigen in circulation and 
interstitial areas, since small-latticed complexes were not de-
posited in these structures. Alte rnat ively, influx of phagocytic 
cells could lead to phagocytosis and degradation of t he com-
p lexes. This possibility was excluded by the fact that at 48 and 
72 h after injection of the complexes no inflammation was 
observed by light microscopic examination of the skin. 
The charge of antibodies in immune complexes significant ly 
altered the deposition of complexes in skin. First of all, a lthough 
an t i-HSA alone did not localize in skin, cationized anti-HSA (anti-HSAw ) deposited extensively in the interstitium and 
vessels at early time points. Of particular interest was the 
finding that staining for cationized antibodies at the DEJ 
increased over time and persisted even longer than in glomeruli . 
The delayed appearance at the junction probably represented 
t he necessary t ime for ant ibodies to traverse the interstitial 
space and interact with the fixed junctional anionic glycopro-
teins t hat have been described by others (21] . The reasons for 
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FIG 3. Skin immunofluoresce nce 
patterns afte r s taining wit h fluorescein-
ated antirabbit lgG . After injection of 5 
mg of ant i-HSAED alone, the flank shows 
both in te rstit ial and early DEJ staining 
(arrows) at 4 h (A), more prom inent. 
staining at t he DEJ at 12 h (B), and 
some persistence at t he DEJ by 48 h (C). 
T he lip at 4 h (D), 12 h (E), and 48 h 
(F) fo llows a similar but more in tense 
pattern. Note the autofluorescence of 
hair shafts in (D). X 500. 
FIG 4. S kin immunofluorescence 
patte rns after staining with fluorescein -
ated antirabbit JgG. After injection of 
5xAgAbED t he fl ank shows prominent. 
vascular staining with early DEJ stai n-
ing (a rrows) at 4 h (A), some increased 
junctional staining at 12 h (B) that per-
sists at 48 h (C) . The vascula r staining 
remains intense at all t hese t ime points 
(C). The lip at 4 h (D), 12 h (E), and 48 
h (F) has a simila r but more intense 
patte rn. x 500. 
persistence of positively charged ant ibodies at the DEJ for 
longer t imes t han in glomeruli are not clear. A slower turnover 
of the tixed negative charges or t ighter electrostatic interactions 
could lead to t his finding. 
Immune complexes made with cationized a nt ibodies 
(5XAgAblm) and containing large latt ices deposited extensively 
in t he skin , forming dense, t ight clusters surrounding dermal 
vessels with overriding a reas of junctional staining. Deposition 
at the DEJ gradually increased over t ime, peaking at 12 h, with 
only minimal clearing of vascular or inte rstitia l deposits within 
the 48 h of study. Compared to anti-HSA~m alone, junctional 
sta ining was more extensive, intense, and prolonged. The de-
posits at the DEJ most likely resulted from the deposition of 
immune complexes. The presence of HSA at the DEJ must be 
due to t he presence of complexes since free HSA did not deposit . 
Furthermore, the presence of antigen and antibody is unlikely 
to be due to in vivo dissociation of complexes with ini t ial 
deposition of cationi zed antibody followed by antigen since 
complexes were in ant igen excess at all t imes and therefore 
presence of free a nt ibody is unlikely even t hough unreactive 
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cationized IgG was present in injected complexes. In vitro 
dilution of complexes with mouse sera did not cause dissocia-
tion . In addition, free Abw and AgAb,m are cleared rapidly from 
circulation and thus in vivo conditions create an even higher 
degree of antigen excess. Thus, it is reasonable to conclude that 
ci rculating immune complexes with positively charged antibod-
ies have access to t he DEJ and can deposit at this site, and 
that it is the positive charge on the antibody molecule that is 
important in this localization. 
The mechanism of immunoglobulin deposition at the DEJ in 
lupus erythematosus and other cutaneous diseases has n ever 
been fu lly elucidated. Some observations have suggested in situ 
formation of immune complexes a rising from epidermal cell 
DNA breakdown products and circulating antibodies. For ex-
ample, Natali a nd Tan were able to produce a pos itive lupus 
band by preimmunizing mice with t hymine dimers and subse-
quent exposure of mice to ultraviolet radiation [24) . lzui et al 
s howed DNA to have affinity for glomeru lar basement mem-
bra nes and skin collagen while preformed DNA- anti-DNA 
complexes did not have this affinity, suggesting the antigen 
may deposit at specifi c sites initially, followed by antibody 
[25]. Only indirect evidence has suggested the deposition of 
circulating immune complexes at t he DEJ. For example, the 
presence of immunoglobulin deposits at the DEJ has correlated 
with tests for circu lating immune complexes [26]. 
ln view of the described results it is of interest that Ebling 
and H a hn showed t hat antibodies to DNA in sera and renal 
e luates of MRL/ 1 and NZB/ W mice were more cationic (pi 
8.0-8.5) than normal lgG [27]. The positive charge on a nti-
DNA may a lso contribute to deposition of circulating immune 
complexes at t he DEJ in these murine models and in human 
disease. Other cationic antibodies may also deposit at the DEJ 
alone or as complexes, and may explain the diverse group of 
disorders in which a positive lupus band occurs. 
The authors wish to thank Dr. V. J oyce Gauthier for her expert 
advice and Ms. Nisa Rachie for her secretaria l assista nce. 
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